IBOTTA INC-CL A (IBTA) Fundamental Analysis & Valuation

NYSE:IBTA • US4510511060

Current stock price

35.25 USD
-0.2 (-0.56%)
At close:
35.25 USD
0 (0%)
After Hours:

This IBTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IBTA Profitability Analysis

1.1 Basic Checks

  • In the past year IBTA was profitable.
  • IBTA had a positive operating cash flow in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of IBTA (0.68%) is better than 74.44% of its industry peers.
  • IBTA's Return On Equity of 1.24% is fine compared to the rest of the industry. IBTA outperforms 74.44% of its industry peers.
  • The Return On Invested Capital of IBTA (0.49%) is comparable to the rest of the industry.
  • IBTA had an Average Return On Invested Capital over the past 3 years of 13.82%. This is significantly above the industry average of 7.63%.
  • The 3 year average ROIC (13.82%) for IBTA is well above the current ROIC(0.49%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.68%
ROE 1.24%
ROIC 0.49%
ROA(3y)7.58%
ROA(5y)N/A
ROE(3y)50.92%
ROE(5y)N/A
ROIC(3y)13.82%
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 50 -50 100 150

1.3 Margins

  • IBTA has a Profit Margin of 1.04%. This is in the better half of the industry: IBTA outperforms 74.44% of its industry peers.
  • IBTA has a Operating Margin (0.57%) which is in line with its industry peers.
  • Looking at the Gross Margin, with a value of 79.25%, IBTA belongs to the top of the industry, outperforming 95.56% of the companies in the same industry.
  • IBTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.57%
PM (TTM) 1.04%
GM 79.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.49%
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IBTA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IBTA is creating some value.
  • The number of shares outstanding for IBTA has been reduced compared to 1 year ago.
  • IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • IBTA has an Altman-Z score of 2.87. This is not the best score and indicates that IBTA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • IBTA has a Altman-Z score of 2.87. This is amongst the best in the industry. IBTA outperforms 82.22% of its industry peers.
  • There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.87
ROIC/WACC0.05
WACC8.9%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that IBTA should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.96, IBTA is doing good in the industry, outperforming 71.11% of the companies in the same industry.
  • IBTA has a Quick Ratio of 1.96. This is a normal value and indicates that IBTA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.96, IBTA is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IBTA Growth Analysis

3.1 Past

  • IBTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.05%.
  • The Revenue has decreased by -6.77% in the past year.
  • Measured over the past years, IBTA shows a quite strong growth in Revenue. The Revenue has been growing by 17.57% on average per year.
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.97%
Revenue 1Y (TTM)-6.77%
Revenue growth 3Y17.57%
Revenue growth 5YN/A
Sales Q2Q%-10.02%

3.2 Future

  • Based on estimates for the next years, IBTA will show a decrease in Earnings Per Share. The EPS will decrease by -9.22% on average per year.
  • The Revenue is expected to grow by 7.57% on average over the next years.
EPS Next Y-616.8%
EPS Next 2Y-132.13%
EPS Next 3Y-9.22%
EPS Next 5YN/A
Revenue Next Year1.58%
Revenue Next 2Y5.2%
Revenue Next 3Y7.57%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. IBTA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 235.00, the valuation of IBTA can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of IBTA indicates a somewhat cheap valuation: IBTA is cheaper than 62.22% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, IBTA is valued quite expensively.
  • IBTA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 235
Fwd PE N/A
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBTA indicates a slightly more expensive valuation: IBTA is more expensive than 61.11% of the companies listed in the same industry.
  • IBTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBTA is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.79
EV/EBITDA 63.63
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as IBTA's earnings are expected to decrease with -9.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-132.13%
EPS Next 3Y-9.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IBTA Dividend Analysis

5.1 Amount

  • IBTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IBTA Fundamentals: All Metrics, Ratios and Statistics

IBOTTA INC-CL A

NYSE:IBTA (4/17/2026, 8:20:15 PM)

After market: 35.25 0 (0%)

35.25

-0.2 (-0.56%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners54.35%
Inst Owner Change-0.01%
Ins Owners16%
Ins Owner Change6.97%
Market Cap840.71M
Revenue(TTM)342.39M
Net Income(TTM)3.58M
Analysts51.43
Price Target28.41 (-19.4%)
Short Float %36.89%
Short Ratio9.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)660.91%
Min EPS beat(2)-292.16%
Max EPS beat(2)1613.97%
EPS beat(4)2
Avg EPS beat(4)393.53%
Min EPS beat(4)-292.16%
Max EPS beat(4)1613.97%
EPS beat(8)4
Avg EPS beat(8)200.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.97%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)4.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-6.83%
Max Revenue beat(4)4.28%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)-0.51%
EPS NQ rev (1m)0.95%
EPS NQ rev (3m)-25.11%
EPS NY rev (1m)-30.07%
EPS NY rev (3m)-334.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.15%
Valuation
Industry RankSector Rank
PE 235
Fwd PE N/A
P/S 2.46
P/FCF 13.79
P/OCF 8.82
P/B 2.92
P/tB 2.92
EV/EBITDA 63.63
EPS(TTM)0.15
EY0.43%
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)2.56
FCFY7.25%
OCF(TTM)3.99
OCFY11.33%
SpS14.36
BVpS12.06
TBVpS12.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.38007 (-81.9%)
Profitability
Industry RankSector Rank
ROA 0.68%
ROE 1.24%
ROCE 0.62%
ROIC 0.49%
ROICexc 1.18%
ROICexgc 1.18%
OM 0.57%
PM (TTM) 1.04%
GM 79.25%
FCFM 17.81%
ROA(3y)7.58%
ROA(5y)N/A
ROE(3y)50.92%
ROE(5y)N/A
ROIC(3y)13.82%
ROIC(5y)N/A
ROICexc(3y)31.21%
ROICexc(5y)N/A
ROICexgc(3y)31.49%
ROICexgc(5y)N/A
ROCE(3y)17.49%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.49%
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 412.3%
Cap/Sales 10.02%
Interest Coverage 7.93
Cash Conversion 926.88%
Profit Quality 1705.48%
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 2.87
F-Score6
WACC8.9%
ROIC/WACC0.05
Cap/Depr(3y)220.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.12%
Cap/Sales(5y)N/A
Profit Quality(3y)632.43%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.97%
EPS Next Y-616.8%
EPS Next 2Y-132.13%
EPS Next 3Y-9.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.77%
Revenue growth 3Y17.57%
Revenue growth 5YN/A
Sales Q2Q%-10.02%
Revenue Next Year1.58%
Revenue Next 2Y5.2%
Revenue Next 3Y7.57%
Revenue Next 5YN/A
EBIT growth 1Y-92.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1631.37%
EBIT Next 3Y212.58%
EBIT Next 5YN/A
FCF growth 1Y-42.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.81%
OCF growth 3YN/A
OCF growth 5YN/A

IBOTTA INC-CL A / IBTA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBTA.


Can you provide the valuation status for IBOTTA INC-CL A?

ChartMill assigns a valuation rating of 2 / 10 to IBOTTA INC-CL A (IBTA). This can be considered as Overvalued.


How profitable is IBOTTA INC-CL A (IBTA) stock?

IBOTTA INC-CL A (IBTA) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for IBTA stock?

The Earnings per Share (EPS) of IBOTTA INC-CL A (IBTA) is expected to decline by -616.8% in the next year.